Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping Yuan

Showing results (1051-1060 of 1,116) with videos related to

Pageof 112
Sort By:
Oncology Letters|December 2, 2014
Primary hepatic non-Hodgkin's lymphoma with rectal cancer: A case reportGuo-Bin Wu, Chao-Yuan Huang, Shan Huang, et al.
Ebiomedicine|May 15, 2017
BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal CancerPeipei Xue, Fanfan Zeng, Qiuhong Duan, et al.
Internal Medicine Journal|April 2, 2024
Sleep-disordered breathing and nocturnal hypoxemia in chronic thromboembolic pulmonary diseaseHui-Ting Li, Ping Yuan, Rong Jiang, et al.
JNCI Cancer Spectrum|January 25, 2021
Pilot Study Assessing Tolerability and Metabolic Effects of Metformin in Patients With Li-Fraumeni SyndromeFarzana L Walcott, Ping-Yuan Wang, Christine M Bryla, et al.
Human Genetics|March 21, 2015
Characterization of 26 deletion CNVs reveals the frequent occurrence of micro-mutations within the breakpoint-flanking regions and frequent repair of double-strand breaks by templated insertions derived from remote genomic regionsYe Wang, Peiqiang Su, Bin Hu, et al.
Clinical Cardiology|February 25, 2024
Impact of different sequential triple oral combination therapies based selexipag on outcomes in pulmonary arterial hypertensionXiaoyi Hu, Ping Yuan, Jun Chen, et al.
Journal of the American Heart Association|May 14, 2026
Amonafide Targeting NTSR1-PI3K/AKT/mTOR Signaling Attenuates Vascular Remodeling in Pulmonary Arterial HypertensionYong-Jian Zhu, Jie-Jian Kou, Ya-Cong Bo, et al.
Frontiers in Cardiovascular Medicine|October 13, 2025
Right heart remodeling in end-stage pulmonary arterial hypertension and the impact of treatment intensitySu-Gang Gong, Qi-Hang Zhang, Jia-Yi Zhang, et al.
Frontiers in Cardiovascular Medicine|December 26, 2022
Efficacy and safety of switching from bosentan or ambrisentan to macitentan in pulmonary arterial hypertension: A systematic review and meta-analysisJie Li, Zu-Yuan Yang, Shang Wang, et al.
Frontiers in Medicine|April 22, 2022
A Study of the Efficacy and Safety of Aerobic Exercise Training in Pulmonary Arterial Hypertension (the Saturday Study): Protocol for a Prospective, Randomized, and Controlled TrialRong Jiang, Lan Wang, Ping Yuan, et al.
Pageof 112

Showing results (1051-1060 of 1,116) with videos related to

Sort By:
Pageof 112
Oncology Letters|December 2, 2014
Primary hepatic non-Hodgkin's lymphoma with rectal cancer: A case reportGuo-Bin Wu, Chao-Yuan Huang, Shan Huang, et al.
Ebiomedicine|May 15, 2017
BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal CancerPeipei Xue, Fanfan Zeng, Qiuhong Duan, et al.
Internal Medicine Journal|April 2, 2024
Sleep-disordered breathing and nocturnal hypoxemia in chronic thromboembolic pulmonary diseaseHui-Ting Li, Ping Yuan, Rong Jiang, et al.
JNCI Cancer Spectrum|January 25, 2021
Pilot Study Assessing Tolerability and Metabolic Effects of Metformin in Patients With Li-Fraumeni SyndromeFarzana L Walcott, Ping-Yuan Wang, Christine M Bryla, et al.
Human Genetics|March 21, 2015
Characterization of 26 deletion CNVs reveals the frequent occurrence of micro-mutations within the breakpoint-flanking regions and frequent repair of double-strand breaks by templated insertions derived from remote genomic regionsYe Wang, Peiqiang Su, Bin Hu, et al.
Clinical Cardiology|February 25, 2024
Impact of different sequential triple oral combination therapies based selexipag on outcomes in pulmonary arterial hypertensionXiaoyi Hu, Ping Yuan, Jun Chen, et al.
Journal of the American Heart Association|May 14, 2026
Amonafide Targeting NTSR1-PI3K/AKT/mTOR Signaling Attenuates Vascular Remodeling in Pulmonary Arterial HypertensionYong-Jian Zhu, Jie-Jian Kou, Ya-Cong Bo, et al.
Frontiers in Cardiovascular Medicine|October 13, 2025
Right heart remodeling in end-stage pulmonary arterial hypertension and the impact of treatment intensitySu-Gang Gong, Qi-Hang Zhang, Jia-Yi Zhang, et al.
Frontiers in Cardiovascular Medicine|December 26, 2022
Efficacy and safety of switching from bosentan or ambrisentan to macitentan in pulmonary arterial hypertension: A systematic review and meta-analysisJie Li, Zu-Yuan Yang, Shang Wang, et al.
Frontiers in Medicine|April 22, 2022
A Study of the Efficacy and Safety of Aerobic Exercise Training in Pulmonary Arterial Hypertension (the Saturday Study): Protocol for a Prospective, Randomized, and Controlled TrialRong Jiang, Lan Wang, Ping Yuan, et al.
Pageof 112